Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

European Core Health Indicators - status and perspectives.

Fehr A, Tijhuis MJ, Hense S, Urbanski D, Achterberg P, Ziese T.

Arch Public Health. 2018 Aug 3;76:52. doi: 10.1186/s13690-018-0298-9. eCollection 2018.

2.

The association between dietary energy density and type 2 diabetes in Europe: results from the EPIC-InterAct Study.

InterAct Consortium, van den Berg SW, van der A DL, Spijkerman AM, van Woudenbergh GJ, Tijhuis MJ, Amiano P, Ardanaz E, Beulens JW, Boeing H, Clavel-Chapelon F, Crowe FL, de Lauzon-Guillain B, Fagherazzi G, Franks PW, Freisling H, Gonzalez C, Grioni S, Halkjaer J, Huerta JM, Huybrechts I, Kaaks R, Khaw KT, Masala G, Nilsson PM, Overvad K, Panico S, Quirós JR, Rolandsson O, Sacerdote C, Sánchez MJ, Schulze MB, Slimani N, Struijk EA, Tjonneland A, Tumino R, Sharp SJ, Langenberg C, Forouhi NG, Feskens EJ, Riboli E, Wareham NJ.

PLoS One. 2013 May 16;8(5):e59947. doi: 10.1371/journal.pone.0059947. Print 2013.

3.

Looking beyond borders: integrating best practices in benefit-risk analysis into the field of food and nutrition.

Tijhuis MJ, Pohjola MV, Gunnlaugsdóttir H, Kalogeras N, Leino O, Luteijn JM, Magnússon SH, Odekerken-Schröder G, Poto M, Tuomisto JT, Ueland O, White BC, Holm F, Verhagen H.

Food Chem Toxicol. 2012 Jan;50(1):77-93. doi: 10.1016/j.fct.2011.11.044. Epub 2011 Dec 2. Review.

PMID:
22142687
4.

State of the art in benefit-risk analysis: economics and marketing-finance.

Kalogeras N, Odekerken-Schröder G, Pennings JM, Gunnlaugsdóttir H, Holm F, Leino O, Luteijn JM, Magnússon SH, Pohjola MV, Tijhuis MJ, Tuomisto JT, Ueland Ø, White BC, Verhagen H.

Food Chem Toxicol. 2012 Jan;50(1):56-66. doi: 10.1016/j.fct.2011.07.066. Epub 2011 Aug 18. Review.

PMID:
21871522
5.

State of the art in benefit-risk analysis: environmental health.

Pohjola MV, Leino O, Kollanus V, Tuomisto JT, Gunnlaugsdóttir H, Holm F, Kalogeras N, Luteijn JM, Magnússon SH, Odekerken G, Tijhuis MJ, Ueland Ø, White BC, Verhagen H.

Food Chem Toxicol. 2012 Jan;50(1):40-55. doi: 10.1016/j.fct.2011.06.004. Epub 2011 Jun 12. Review.

PMID:
21708210
6.

State of the art in benefit-risk analysis: medicines.

Luteijn JM, White BC, Gunnlaugsdóttir H, Holm F, Kalogeras N, Leino O, Magnússon SH, Odekerken G, Pohjola MV, Tijhuis MJ, Tuomisto JT, Ueland Ø, McCarron PA, Verhagen H.

Food Chem Toxicol. 2012 Jan;50(1):26-32. doi: 10.1016/j.fct.2011.06.008. Epub 2011 Jun 12. Review.

PMID:
21683115
7.

State of the art in benefit-risk analysis: consumer perception.

Ueland Ø, Gunnlaugsdottir H, Holm F, Kalogeras N, Leino O, Luteijn JM, Magnússon SH, Odekerken G, Pohjola MV, Tijhuis MJ, Tuomisto JT, White BC, Verhagen H.

Food Chem Toxicol. 2012 Jan;50(1):67-76. doi: 10.1016/j.fct.2011.06.006. Epub 2011 Jun 12. Review.

PMID:
21683114
8.

State of the art in benefit-risk analysis: food and nutrition.

Tijhuis MJ, de Jong N, Pohjola MV, Gunnlaugsdóttir H, Hendriksen M, Hoekstra J, Holm F, Kalogeras N, Leino O, van Leeuwen FX, Luteijn JM, Magnússon SH, Odekerken G, Rompelberg C, Tuomisto JT, Ueland Ø, White BC, Verhagen H.

Food Chem Toxicol. 2012 Jan;50(1):5-25. doi: 10.1016/j.fct.2011.06.010. Epub 2011 Jun 12. Review.

PMID:
21679741
9.

State of the art in benefit-risk analysis: food microbiology.

Magnússon SH, Gunnlaugsdóttir H, Loveren Hv, Holm F, Kalogeras N, Leino O, Luteijn JM, Odekerken G, Pohjola MV, Tijhuis MJ, Tuomisto JT, Ueland Ø, White BC, Verhagen H.

Food Chem Toxicol. 2012 Jan;50(1):33-9. doi: 10.1016/j.fct.2011.06.005. Epub 2011 Jun 12. Review.

PMID:
21679739
10.

State of the art in benefit-risk analysis: introduction.

Verhagen H, Tijhuis MJ, Gunnlaugsdóttir H, Kalogeras N, Leino O, Luteijn JM, Magnússon SH, Odekerken G, Pohjola MV, Tuomisto JT, Ueland Ø, White BC, Holm F.

Food Chem Toxicol. 2012 Jan;50(1):2-4. doi: 10.1016/j.fct.2011.06.007. Epub 2011 Jun 12. Review.

PMID:
21679738
11.

Impact of substituting added sugar in carbonated soft drinks by intense sweeteners in young adults in the Netherlands: example of a benefit-risk approach.

Hendriksen MA, Tijhuis MJ, Fransen HP, Verhagen H, Hoekstra J.

Eur J Nutr. 2011 Feb;50(1):41-51. doi: 10.1007/s00394-010-0113-z. Epub 2010 Apr 29.

PMID:
20429009
12.

The influence of fruit and vegetable consumption and genetic variation on NAD(P)H:quinone oxidoreductase (NQO1) phenotype in an endoscopy-based population.

Tijhuis MJ, Boerboom AM, Visker MH, Op den Camp L, Nagengast FM, Tan AC, Rietjens IM, Kok FJ, Aarts JM, Kampman E.

Nutr Cancer. 2008;60(2):204-15. doi: 10.1080/01635580701684849.

PMID:
18444152
13.

NQO1 and NFE2L2 polymorphisms, fruit and vegetable intake and smoking and the risk of colorectal adenomas in an endoscopy-based population.

Tijhuis MJ, Visker MH, Aarts JM, Laan W, de Boer SY, Kok FJ, Kampman E.

Int J Cancer. 2008 Apr 15;122(8):1842-8.

14.

Glutathione S-transferase phenotypes in relation to genetic variation and fruit and vegetable consumption in an endoscopy-based population.

Tijhuis MJ, Visker MH, Aarts JM, Peters WH, Roelofs HM, den Camp LO, Rietjens IM, Boerboom AM, Nagengast FM, Kok FJ, Kampman E.

Carcinogenesis. 2007 Apr;28(4):848-57. Epub 2006 Oct 27.

PMID:
17071629
15.

GSTP1 and GSTA1 polymorphisms interact with cruciferous vegetable intake in colorectal adenoma risk.

Tijhuis MJ, Wark PA, Aarts JM, Visker MH, Nagengast FM, Kok FJ, Kampman E.

Cancer Epidemiol Biomarkers Prev. 2005 Dec;14(12):2943-51.

16.

Protective effect of nonsteroidal anti-inflammatory drugs on colorectal adenomas is modified by a polymorphism in peroxisome proliferator-activated receptor delta.

Siezen CL, Tijhuis MJ, Kram NR, van Soest EM, de Jong DJ, Fodde R, van Kranen HJ, Kampman E.

Pharmacogenet Genomics. 2006 Jan;16(1):43-50.

PMID:
16344721

Supplemental Content

Loading ...
Support Center